RU93004970A - Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция - Google Patents

Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция

Info

Publication number
RU93004970A
RU93004970A RU93004970/04A RU93004970A RU93004970A RU 93004970 A RU93004970 A RU 93004970A RU 93004970/04 A RU93004970/04 A RU 93004970/04A RU 93004970 A RU93004970 A RU 93004970A RU 93004970 A RU93004970 A RU 93004970A
Authority
RU
Russia
Prior art keywords
cycloalkyl
derivatives
pharmaceutical composition
substituted glutaramide
substituted
Prior art date
Application number
RU93004970/04A
Other languages
English (en)
Other versions
RU2108322C1 (ru
Inventor
Кристофер Данилевич Джон
Джеймс Кейт
Юрек Кобилеки Ричард
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888820844A external-priority patent/GB8820844D0/en
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Publication of RU93004970A publication Critical patent/RU93004970A/ru
Application granted granted Critical
Publication of RU2108322C1 publication Critical patent/RU2108322C1/ru

Links

Claims (1)

  1. Описываются циклоалкил-замещенные глутарамидные производные общей формулы
    Figure 00000001

    Описываются также фармацевтически приемлемые соли и биопредшественники указанных соединений, применение композиции на их основе.
RU93004970A 1988-09-05 1993-05-24 Производные циклоалкилзамещенного глутарамида и фармацевтическая композиция на их основе RU2108322C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8820844.2 1988-09-05
GB888820844A GB8820844D0 (en) 1988-09-05 1988-09-05 Therapeutic agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU4614874 Division

Publications (2)

Publication Number Publication Date
RU93004970A true RU93004970A (ru) 1997-04-10
RU2108322C1 RU2108322C1 (ru) 1998-04-10

Family

ID=10643114

Family Applications (2)

Application Number Title Priority Date Filing Date
SU894614874A RU2012556C1 (ru) 1988-09-05 1989-09-04 Способ получения производных циклоалкилглутарамида или их фармацевтически приемлемых солей
RU93004970A RU2108322C1 (ru) 1988-09-05 1993-05-24 Производные циклоалкилзамещенного глутарамида и фармацевтическая композиция на их основе

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU894614874A RU2012556C1 (ru) 1988-09-05 1989-09-04 Способ получения производных циклоалкилглутарамида или их фармацевтически приемлемых солей

Country Status (30)

Country Link
US (1) US4975444A (ru)
EP (1) EP0358398B1 (ru)
JP (1) JPH0660144B2 (ru)
CN (1) CN1031051C (ru)
AT (1) ATE86606T1 (ru)
AU (1) AU604195B2 (ru)
CA (1) CA1341046C (ru)
CY (1) CY1811A (ru)
CZ (1) CZ282142B6 (ru)
DD (1) DD284222A5 (ru)
DE (1) DE68905272T2 (ru)
DK (1) DK175082B1 (ru)
EG (1) EG18936A (ru)
ES (1) ES2054009T3 (ru)
FI (1) FI111715B (ru)
GB (1) GB8820844D0 (ru)
HK (1) HK130394A (ru)
HU (2) HU215440B (ru)
IE (1) IE62020B1 (ru)
IL (1) IL91460A (ru)
MX (1) MX17418A (ru)
MY (1) MY106606A (ru)
NO (1) NO177747C (ru)
NZ (1) NZ230550A (ru)
PH (1) PH26272A (ru)
PL (1) PL161527B1 (ru)
PT (1) PT91623B (ru)
RU (2) RU2012556C1 (ru)
YU (1) YU168489A (ru)
ZA (1) ZA896760B (ru)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8925933D0 (en) * 1989-11-16 1990-01-04 Pfizer Ltd Glutaric acid derivatives and preparation thereof
US5260467A (en) * 1989-11-16 1993-11-09 Pfizer Inc. Glutaric acid derivatives and preparation thereof
US5157138A (en) * 1989-11-16 1992-10-20 Pfizer, Inc. Glutaric acid derivatives and preparation thereof
US5389610A (en) * 1989-11-21 1995-02-14 Schering Corporation Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
GB9004260D0 (en) * 1990-02-26 1990-04-18 Pfizer Ltd Therapeutic agents
US5166143A (en) * 1990-05-31 1992-11-24 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
FR2665440B1 (fr) * 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5643921A (en) * 1990-09-26 1997-07-01 E.R. Squibb & Sons, Inc. Cardiopulmonary bypass and organ transplant using a potassium channel activator
DE4036706A1 (de) * 1990-11-17 1992-05-21 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
GB9103454D0 (en) * 1991-02-19 1991-04-03 Pfizer Ltd Therapeutic agents
US5298492A (en) * 1992-08-04 1994-03-29 Schering Corporation Diamino acid derivatives as antihypertensives
US5208236A (en) * 1992-09-23 1993-05-04 Schering Corporation N-(acylaminomethyl)glutaryl amino acids and use
DE69424846T2 (de) * 1993-11-16 2000-11-16 Novartis Ag Zyklische Aminosäure-Derivate mit ACE und NEP inhibierender Aktivität
GB9324931D0 (en) * 1993-12-04 1994-01-26 Pfizer Ltd Glutaramide derivatives
US5512592A (en) * 1994-09-09 1996-04-30 Wake Forest University Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
AU8063098A (en) * 1997-06-10 1998-12-30 Eli Lilly And Company Combinatorial process for preparing substituted phenylalanine libraries
JP4788939B2 (ja) 1999-11-18 2011-10-05 味の素株式会社 新規フェニルアラニン誘導体
CA2433553A1 (en) * 2001-02-01 2002-08-08 Shire Laboratories Inc. Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
EP1397160A1 (en) * 2001-04-30 2004-03-17 Shire Laboratories Inc. Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
US7160859B2 (en) * 2002-10-11 2007-01-09 University Of Medicine & Dentistry Of New Jersey Mst1 modulation of apoptosis in cardiac tissue and modulators of Mst1 for treatment and prevention of cardiac disease
GB0230025D0 (en) * 2002-12-23 2003-01-29 Pfizer Ltd Novel pharmaceuticals
US7045653B2 (en) 2002-12-23 2006-05-16 Pfizer, Inc. Pharmaceuticals
GB0230036D0 (en) * 2002-12-23 2003-01-29 Pfizer Ltd Novel pharmaceuticals
EP2234608A2 (en) 2007-12-11 2010-10-06 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
WO2010132127A1 (en) 2009-05-13 2010-11-18 Intra-Cellular Therapies, Inc. Organic compounds
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
MX354476B (es) 2010-12-15 2018-03-07 Theravance Inc Inhibidores de neprilisina.
AU2011343899B2 (en) 2010-12-15 2016-06-30 Theravance Biopharma R&D Ip, Llc Neprilysin inhibitors
ES2564275T3 (es) 2011-02-17 2016-03-21 Theravance Biopharma R&D Ip, Llc Derivados aminobutíricos sustituidos como inhibidores de neprilisina
WO2012112742A1 (en) 2011-02-17 2012-08-23 Theravance, Inc. Substituted aminobutyric derivatives as neprilysin inhibitors
US8686184B2 (en) 2011-05-31 2014-04-01 Theravance, Inc. Neprilysin inhibitors
CA2835216A1 (en) 2011-05-31 2012-12-06 Theravance, Inc. Neprilysin inhibitors
CN103582630B (zh) 2011-05-31 2016-08-17 施万生物制药研发Ip有限责任公司 脑啡肽酶抑制剂
TWI560172B (en) 2011-11-02 2016-12-01 Theravance Biopharma R&D Ip Llc Neprilysin inhibitors
CA2871292A1 (en) 2012-05-31 2013-12-05 Theravance Biopharma R&D Ip, Llc Nitric oxide donor neprilysin inhibitors
AU2013271537B2 (en) 2012-06-08 2017-05-11 Theravance Biopharma R&D Ip, Llc Neprilysin inhibitors
US8871792B2 (en) 2012-06-08 2014-10-28 Theravance Biopharma R&D Ip, Llc Neprilysin inhibitors
JP6092390B2 (ja) 2012-08-08 2017-03-08 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー ネプリライシン阻害剤
WO2014127331A1 (en) 2013-02-17 2014-08-21 Intra-Cellular Therapies, Inc. Novel uses
EP2964616B1 (en) 2013-03-05 2017-05-03 Theravance Biopharma R&D IP, LLC Neprilysin inhibitors
AU2015211041B2 (en) 2014-01-30 2018-11-08 Theravance Biopharma R&D Ip, Llc 5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin inhibitors
CA2934936A1 (en) 2014-01-30 2015-08-06 Theravance Biopharma R&D Ip, Llc Neprilysin inhibitors
JP6591530B2 (ja) 2014-08-07 2019-10-16 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 有機化合物
US9433598B2 (en) 2015-02-11 2016-09-06 Theravance Biopharma R&D Ip, Llc (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid
JP6714009B2 (ja) 2015-02-19 2020-06-24 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー （２ｒ，４ｒ）−５−（５’−クロロ−２’−フルオロビフェニル−４−イル）−２−ヒドロキシ−４−［（５−メチルオキサゾール−２−カルボニル）アミノ］ペンタン酸
TWI731943B (zh) 2016-03-08 2021-07-01 美商施萬生物製藥研發Ｉｐ有限責任公司 結晶型（2s，4r）－5－（5’－氯－2’－氟－［1，1’－聯苯］－4－基）－2－（乙氧基甲基）－4－（3－羥基異㗁唑－5－甲醯胺基）－2－甲基戊酸及其用途
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
JP7401442B2 (ja) 2018-01-31 2023-12-19 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3376649D1 (en) * 1982-06-17 1988-06-23 Schering Corp Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions
DE3565677D1 (de) * 1984-06-08 1988-11-24 Ciba Geigy Ag N-substituted butyramide derivatives
EP0225292A3 (en) * 1985-12-06 1988-11-30 Ciba-Geigy Ag Certain n-substituted butyramide derivatives
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제
GB8811873D0 (en) * 1988-05-19 1988-06-22 Pfizer Ltd Therapeutic agents
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents

Similar Documents

Publication Publication Date Title
RU93004970A (ru) Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция
RU93055882A (ru) Производные n-сульфонил-2-оксоиндола, способ их получения, исходные для их получения, фармацевтическая композиция на их основе
RU92004593A (ru) Производные гетероциклилметил-хромана в виде смеси изомеров или отдельных изомеров или их соли, способ их получения и лекарственное средство
IT1190727B (it) Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
DK319785D0 (da) Acetyleniske phenoxypropanolderivater
EP0347749A3 (en) Pyrazoloacridone derivatives with anti-tumoral activity
RU94021365A (ru) Производные метилпиперазиназепина, способ их получения, фармацевтическая композиция на их основе и использование производных в качестве фармацевтически активного вещества
IT1218322B (it) Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
IT8922246A0 (it) Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone
RU93047049A (ru) Новые производные фосфолипидов
IT8219486A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
RU93046324A (ru) Производное 21-хлорпрегнана, способ его получения, фармкомпозиция на его основе, способ его получения
RU93004708A (ru) Производные замещенного пирролидина и их терапевтически приемлемые соли, способ их получения и фармацевтическая композиция
IT1190942B (it) Composto ad attivita' analgesica ed antiinfiammatoria,suo procedimento di preparazione e relative composizioni farmaceutiche
RU93004972A (ru) Трополоновые производные и фармацевтическая композиция для предотвращения и лечения ишемических болезней
RU93047670A (ru) Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе
IT8219215A0 (it) Composto ad attivita' analgesica, antiinfiammatoria e mucoregolatrice procedimento per la sua preparazione e relative composizioni farmaceutiche
IT8820927A0 (it) Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8721158A0 (it) Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8219213A0 (it) Composto ad attivita' mucoregolatri ce e antitosse,procedimento per lasua preparazione e relative composizioni farmaceutiche
RU93050376A (ru) Полиэтилен гликолевые соединения интерферона
IT8219043A0 (it) Nuovo composto farmacologicamente attivo, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
IT8221552A0 (it) Nuovi composti ad attivita'antineoplastica, procedimetno per la loro preparazione e relative composizioni farmaceutiche.